Quotes for DanCann Pharma A/S
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Jeppe Krog Rasmussen
Chairperson of the Board
- Carsten Trads
Board
- Jeppe Krog Rasmussen
- Christian Carlsen
DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Nordic Growth Opportunities 2 | 41,30 | 41,30 | 2024-01-10 |
Sellers of CannGros ApS | 7,85 | 7,85 | 2021-10-05 |
Alexander Schoeneck | 6,21 | 6,21 | 2022-06-30 |
Futur Pension | 5,56 | 5,56 | 2021-09-30 |
Jeppe Krog Rasmussen | 4,18 | 4,18 | 2023-11-30 |
Morten Martinsen | 1,41 | 1,41 | 2021-12-30 |
Hansen & Nytoft Invest Aps | 1,34 | 1,34 | 2021-08-19 |
Tue Østergaard | 1,28 | 1,28 | 2022-12-31 |
Vavi Invest Aps | 0,88 | 0,88 | 2021-08-19 |
John Frellsen | 0,60 | 0,60 | 2021-07-26 |
2024-11-29 Delårsrapport 2024-Q3